551 related articles for article (PubMed ID: 21241687)
1. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution.
Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC
Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687
[TBL] [Abstract][Full Text] [Related]
2. Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution.
Lozano ML; Rivera J; Corral J; Gonzalez-Conejero R; Vicente V
Cryobiology; 1999 Aug; 39(1):1-12. PubMed ID: 10458897
[TBL] [Abstract][Full Text] [Related]
3. PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma.
Johnson L; Reid S; Tan S; Vidovic D; Marks DC
Transfusion; 2013 Oct; 53(10):2268-77. PubMed ID: 23347144
[TBL] [Abstract][Full Text] [Related]
4. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing.
Valeri CR; Ragno G; Khuri S
Transfusion; 2005 Dec; 45(12):1890-8. PubMed ID: 16371041
[TBL] [Abstract][Full Text] [Related]
5. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles.
Johnson L; Coorey CP; Marks DC
Transfusion; 2014 Aug; 54(8):1917-26. PubMed ID: 24527873
[TBL] [Abstract][Full Text] [Related]
6. Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants.
Xiao H; Harvey K; Labarrere CA; Kovacs R
Cryobiology; 2000 Sep; 41(2):97-105. PubMed ID: 11034788
[TBL] [Abstract][Full Text] [Related]
7. Freezing of Apheresis Platelet Concentrates in 6% Dimethyl Sulfoxide: The First Preliminary Study in Turkey.
Yılmaz S; Çetinkaya RA; Eker İ; Ünlü A; Uyanık M; Tapan S; Pekoğlu A; Pekel A; Erkmen B; Muşabak U; Yılmaz S; Avcı İY; Avcu F; Kürekçi E; Eyigün CP
Turk J Haematol; 2016 Mar; 33(1):28-33. PubMed ID: 25912150
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of UVC pathogen-inactivated platelets.
Waters L; Padula MP; Marks DC; Johnson L
Transfusion; 2019 Jun; 59(6):2093-2102. PubMed ID: 30790288
[TBL] [Abstract][Full Text] [Related]
9. Cooling and freezing damage platelet membrane integrity.
Reid TJ; LaRussa VF; Esteban G; Clear M; Davies L; Shea S; Gorogias M
Cryobiology; 1999 May; 38(3):209-24. PubMed ID: 10328911
[TBL] [Abstract][Full Text] [Related]
10. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide.
Hornsey VS; McMillan L; Morrison A; Drummond O; Macgregor IR; Prowse CV
Transfusion; 2008 Dec; 48(12):2508-14. PubMed ID: 18680547
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison between gamma-irradiated cryopreserved and Day 7 liquid-stored buffy coat-derived platelet components.
Crimmins D; Flanagan P; Charlewood R; Ruggiero K
Transfusion; 2016 Nov; 56(11):2799-2807. PubMed ID: 27526671
[TBL] [Abstract][Full Text] [Related]
12. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved buffy-coat-derived platelets reconstituted in platelet additive solution: A safe and available product with sufficient haemostatic effectiveness.
Lejdarova H; Pacasova R; Tesarova L; Koutna I; Polokova N; Michlickova S; Dolecek M
Transfus Apher Sci; 2021 Jun; 60(3):103110. PubMed ID: 33736955
[TBL] [Abstract][Full Text] [Related]
15. Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryopreservation.
Balint B; Vucetić D; Trajković-Lakić Z; Petakov M; Bugarski D; Brajusković G; Taseski J
Haematologia (Budap); 2002; 32(4):363-75. PubMed ID: 12803111
[TBL] [Abstract][Full Text] [Related]
16. Comparison of various dimethylsulphoxide-containing solutions for cryopreservation of leucoreduced platelet concentrates.
Dijkstra-Tiekstra MJ; de Korte D; Pietersz RN; Reesink HW; van der Meer PF; Verhoeven AJ
Vox Sang; 2003 Nov; 85(4):276-82. PubMed ID: 14633253
[TBL] [Abstract][Full Text] [Related]
17. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T
Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912
[TBL] [Abstract][Full Text] [Related]
18. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution.
Cookson P; Sutherland J; Turner C; Bashir S; Wiltshire M; Hancock V; Smith K; Cardigan R
Transfus Med; 2010 Dec; 20(6):392-402. PubMed ID: 20738829
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of cryopreserved and liquid platelets: potential clinical implications.
Johnson L; Reade MC; Hyland RA; Tan S; Marks DC
Transfusion; 2015 Apr; 55(4):838-47. PubMed ID: 25371169
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a dimethyl sulfoxide-stabilized frozen canine platelet concentrate.
Guillaumin J; Jandrey KE; Norris JW; Tablin F
Am J Vet Res; 2008 Dec; 69(12):1580-6. PubMed ID: 19046004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
